C3718-302
Research payments
$18,111,928
Through program year 2022, $18,111,928 in research payments was reported against C3718-302, across 1,750 payments, paid by Ironwood Pharmaceuticals, Inc.
- Paid by
- Ironwood Pharmaceuticals, Inc
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $11,996 | 4 |
| 2021 | Research | $1,172,243 | 463 |
| 2020 | Research | $7,970,325 | 700 |
| 2019 | Research | $8,957,365 | 583 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
7 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Robert Call Richmond, VA Named on 154 payments
- Joseph James North Chester, VA Named on 153 payments
- Michael Goldstein Great Neck, NY Named on 61 payments
- Marina Raikhel Lomita, CA Named on 36 payments
- Hugh Durrence Charleston, SC Named on 33 payments
- Michael Epstein Annapolis, MD Named on 26 payments
- Edward Cordasco Columbus, OH Named on 26 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.